Skip to main content

Table 2 Factors associated with inappropriate use of antibiotics on bivariate analysis

From: Antibiotic prescribing patterns at children’s outpatient departments of primary care institutions in Southwest China

Characteristic

Total, N (%)

Appropriate use, n (%)

Inappropriate use, n (%)

Chi-square test

Preferred medication

Antibiotic can be used or substituted

Combined use of antibiotics

Incorrect spectrum of antibiotics

Unnecessary use

χ2

P value

Total

137,284

12,991 (9.5)

12,036 (8.8)

3361 (2.4)

3308 (2.4)

105,588 (76.9)

  

Physician-related factors

Sex

      

256.80

<  0.001

  Female

43,202 (31.5)

4642 (10.7)

3247 (7.5)

1041 (2.4)

887 (2.1)

33,385 (77.3)

  

  Male

94,082 (68.5)

8349 (8.9)

8789 (9.3)

2320 (2.5)

2421 (2.6)

72,203 (76.7)

  

Age group (years)

      

523.01

<  0.001

  23–32

48,348 (35.2)

5042 (10.4)

4043 (8.4)

1418 (2.9)

1126 (2.3)

36,719 (75.9)

  

  33–40

46,024 (33.5)

4390 (9.5)

3510 (7.6)

930 (2.0)

921 (2.0)

36,273 (78.8)

  

  41–65

42,912 (31.3)

3559 (8.3)

4483 (10.4)

1013 (2.4)

1261 (2.9)

32,596 (76.0)

  

Professional title

      

146.91

<  0.001

  Associate chief physician

5601 (4.1)

646 (11.5)

535 (9.6)

82 (1.5)

163 (2.9)

4175 (74.5)

  

  Attending physician

16,559 (12.1)

1496 (9.0)

1284 (7.8)

291 (1.8)

353 (2.1)

13,135 (79.3)

  

  Resident physician

115,124 (83.9)

10,849 (9.4)

10,217 (8.9)

2988 (2.6)

2792 (2.4)

88,278 (76.7)

  

Education

      

447.37

<  0.001

  College

57,121 (41.6)

5907 (10.3)

4697 (8.2)

1231 (2.2)

1031 (1.8)

44,255 (77.5)

  

  Junior college

57,979 (42.2)

5333 (9.2)

5607 (9.7)

1549 (2.7)

1518 (2.6)

43,972 (75.8)

  

  Technical secondary school

22,184 (16.2)

1751 (7.9)

1732 (7.8)

581 (2.6)

759 (3.4)

17,361 (78.3)

  

Work duration (years)

      

2466.86

<  0.001

   ≤ 5

30,322 (22.1)

3046 (10.0)

2925 (9.6)

1014 (3.3)

961 (3.2)

22,376 (73.8)

  

  6–10

50,214 (36.6)

4906 (9.8)

2966 (5.9)

903 (1.8)

602 (1.2)

40,837 (81.3)

  

  11–20

22,207 (16.2)

2225 (10.0)

2181 (9.8)

579 (2.6)

592 (2.7)

16,630 (74.9)

  

  21–30

21,077 (15.4)

1782 (8.5)

2338 (11.1)

489 (2.3)

864 (4.1)

15,604 (74.0)

  

  31–39

10,364 (7.5)

840 (8.1)

1521 (14.7)

354 (3.4)

236 (2.3)

7413 (71.5)

  

   ≥ 40

3100 (2.3)

192 (6.2)

105 (3.4)

22 (0.7)

53 (1.7)

2728 (88.0)

  

Patient-related factors

Sex

      

88.17

<  0.001

  Female

63,023 (45.9)

5659 (9.0)

5399 (8.6)

1439 (2.3)

1379 (2.2)

49,147 (78.0)

  

  Male

74,261 (54.1)

7332 (9.9)

6637 (8.9)

1922 (2.6)

1929 (2.6)

56,441 (76.0)

  

Age group (years)

      

475.07

<  0.001

  [0,1]

8417 (6.1)

445 (5.3)

775 (9.2)

251 (3.0)

265 (3.1)

6681 (79.4)

  

  (1,2]

13,806 (10.1)

989 (7.2)

1143 (8.3)

330 (2.4)

359 (2.6)

10,985 (79.6)

  

  (2,5]

38,485 (28.0)

3486 (9.1)

3582 (9.3)

875 (2.3)

957 (2.5)

29,585 (76.9)

  

  (5,11]

46,863 (34.1)

4894 (10.4)

4257 (9.1)

1142 (2.4)

1014 (2.2)

35,556 (75.9)

  

  (11,18]

29,713 (21.6)

3177 (10.7)

2279 (7.7)

763 (2.6)

713 (2.4)

22,781 (76.7)

  

Quartera

      

1312.36

<  0.001

  Q1

32,611 (23.8)

3194 (9.8)

3489 (10.7)

1185 (3.6)

1293 (4.0)

23,450 (71.9)

  

  Q2

22,901 (16.7)

2249 (9.8)

1833 (8.0)

510 (2.2)

489 (2.1)

17,820 (77.8)

  

  Q3

28,002 (20.4)

3050 (10.9)

2542 (9.1)

614 (2.2)

697 (2.5)

21,099 (75.3)

  

  Q4

53,770 (39.2)

4498 (8.4)

4172 (7.8)

1052 (2.0)

829 (1.5)

43,219 (80.4)

  

Antibiotic route

      

20,893.03

<  0.001

  Injection

25,099 (18.3)

1442 (5.7)

3272 (13.0)

2499 (10.0)

2989 (11.9)

14,897 (59.4)

  

  Oral

112,185 (81.7)

11,549 (10.3)

8764 (7.8)

862 (0.8)

319 (0.3)

90,691 (80.8)

  

Insurance

      

1006.17

<  0.001

  Fully out-of-pocket

18,394 (13.4)

1952(10.6)

1982 (10.8)

782 (4.3)

860 (4.7)

12,818 (69.7)

  

  New rural cooperative medical system

118,890 (86.6)

11,039 (9.3)

10,054 (8.5)

2579 (2.2)

2448 (2.1)

92,770 (78.0)

  
  1. aQuarters
  2. Q1: January–March
  3. Q2: April–June
  4. Q3: July–September
  5. Q4: October – December